BRPI0917502A2 - composição farmacêtica, e, métodos para usar um ácido orgânico ou um antioxidante, para evitar a descoloração causada quando ácido tranemaxâmico e ácido ascórbico são incorporados em uma mesma composição, e para produzir uma preparação farmacêutica sólida para administração oral - Google Patents

composição farmacêtica, e, métodos para usar um ácido orgânico ou um antioxidante, para evitar a descoloração causada quando ácido tranemaxâmico e ácido ascórbico são incorporados em uma mesma composição, e para produzir uma preparação farmacêutica sólida para administração oral

Info

Publication number
BRPI0917502A2
BRPI0917502A2 BRPI0917502A BRPI0917502A BRPI0917502A2 BR PI0917502 A2 BRPI0917502 A2 BR PI0917502A2 BR PI0917502 A BRPI0917502 A BR PI0917502A BR PI0917502 A BRPI0917502 A BR PI0917502A BR PI0917502 A2 BRPI0917502 A2 BR PI0917502A2
Authority
BR
Brazil
Prior art keywords
acid
tranemaxamic
antioxidant
incorporated
produce
Prior art date
Application number
BRPI0917502A
Other languages
English (en)
Inventor
Eiichi Mafune
Ken Tujii
Kimiyoshi Shimada
Takeshi Matsushita
Toshio Murakami
Yusuke Mochizuki
Original Assignee
Daiichi Sankyo Healthcare Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41663727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0917502(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daiichi Sankyo Healthcare Co filed Critical Daiichi Sankyo Healthcare Co
Publication of BRPI0917502A2 publication Critical patent/BRPI0917502A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0917502A 2008-08-06 2009-08-05 composição farmacêtica, e, métodos para usar um ácido orgânico ou um antioxidante, para evitar a descoloração causada quando ácido tranemaxâmico e ácido ascórbico são incorporados em uma mesma composição, e para produzir uma preparação farmacêutica sólida para administração oral BRPI0917502A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008203127 2008-08-06
PCT/JP2009/063844 WO2010016509A1 (ja) 2008-08-06 2009-08-05 安定なトラネキサム酸とアスコルビン酸含有医薬組成物

Publications (1)

Publication Number Publication Date
BRPI0917502A2 true BRPI0917502A2 (pt) 2015-11-17

Family

ID=41663727

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0917502A BRPI0917502A2 (pt) 2008-08-06 2009-08-05 composição farmacêtica, e, métodos para usar um ácido orgânico ou um antioxidante, para evitar a descoloração causada quando ácido tranemaxâmico e ácido ascórbico são incorporados em uma mesma composição, e para produzir uma preparação farmacêutica sólida para administração oral

Country Status (8)

Country Link
EP (1) EP2316449B1 (pt)
JP (1) JP5517938B2 (pt)
KR (1) KR101602000B1 (pt)
CN (1) CN102105143B (pt)
BR (1) BRPI0917502A2 (pt)
MX (1) MX2011001071A (pt)
TW (1) TWI477272B (pt)
WO (1) WO2010016509A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5498387B2 (ja) * 2008-09-12 2014-05-21 第一三共ヘルスケア株式会社 変色が抑制された安定な医薬製剤
JP5837847B2 (ja) * 2011-03-04 2015-12-24 第一三共ヘルスケア株式会社 セチリジン塩酸塩を含有する医薬組成物
JP6148454B2 (ja) * 2011-11-11 2017-06-14 ロート製薬株式会社 トラネキサム酸を含む外用及び内服用組成物
WO2016002787A1 (ja) * 2014-06-30 2016-01-07 ロート製薬株式会社 外用剤
CN105030690B (zh) * 2015-07-08 2018-01-16 泰州市澳华生物科技有限公司 维生素c缓释颗粒剂及其生产方法
KR20180133220A (ko) * 2017-06-05 2018-12-13 라이온 가부시키가이샤 구강용 조성물
CN109568201B (zh) * 2018-11-21 2022-02-11 上海中翊日化有限公司 抑制变色组合物、皮肤外用制剂及应用
JP7330716B2 (ja) * 2019-02-21 2023-08-22 アサヒグループ食品株式会社 アミノ酸又はその塩及びビタミンｃ含有組成物の変色抑制方法、並びに粉末組成物、顆粒、及び錠剤
CN111481465B (zh) * 2020-04-21 2020-11-03 泉后(广州)生物科技研究院有限公司 一种抗坏血酸保护剂及其应用
JPWO2023176783A1 (pt) * 2022-03-14 2023-09-21

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2906269B2 (ja) * 1990-03-28 1999-06-14 株式会社資生堂 皮膚外用剤
JPH04243825A (ja) 1991-01-25 1992-08-31 Ss Pharmaceut Co Ltd 色素沈着症治療剤
JPH09286726A (ja) * 1996-04-18 1997-11-04 Takeda Chem Ind Ltd 経口液剤
FR2764189B1 (fr) * 1997-06-09 1999-08-27 Coletica Utilisation de sulfites et metabisulfites, pour la fabrication de compositions cosmetiques ou pharmaceutiques, notamment en dermatologie, a effet inhibiteur de la melanogenese ou a activite depigmentante
EP1068868A3 (en) * 1997-07-08 2001-01-31 Rath, Matthias, Dr. med. Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
CN1365665A (zh) * 2001-01-16 2002-08-28 马蒂亚斯·拉特 用于与细胞外基质退化相关疾病的含有抗坏血酸盐和赖氨酸的协同组合物
JP4111856B2 (ja) * 2002-04-12 2008-07-02 昭和電工株式会社 安定化されたアスコルビン酸誘導体
JP4786127B2 (ja) * 2002-07-12 2011-10-05 任康 高田 色素沈着改善治療薬
AU2003292657A1 (en) * 2002-12-27 2004-07-29 Daiichi Pharmaceutical Co., Ltd. Skin lightening composition
JP2004217655A (ja) * 2002-12-27 2004-08-05 Dai Ichi Seiyaku Co Ltd 美白用組成物
WO2006003965A1 (ja) * 2004-06-30 2006-01-12 Daiichi Sankyo Healthcare Co., Ltd. 美白組成物

Also Published As

Publication number Publication date
CN102105143A (zh) 2011-06-22
TWI477272B (zh) 2015-03-21
JPWO2010016509A1 (ja) 2012-01-26
JP5517938B2 (ja) 2014-06-11
KR101602000B1 (ko) 2016-03-17
EP2316449A4 (en) 2011-08-10
MX2011001071A (es) 2011-04-26
CN102105143B (zh) 2013-03-20
EP2316449A1 (en) 2011-05-04
KR20110039487A (ko) 2011-04-18
WO2010016509A1 (ja) 2010-02-11
TW201010693A (en) 2010-03-16
EP2316449B1 (en) 2013-10-02

Similar Documents

Publication Publication Date Title
BRPI0917502A2 (pt) composição farmacêtica, e, métodos para usar um ácido orgânico ou um antioxidante, para evitar a descoloração causada quando ácido tranemaxâmico e ácido ascórbico são incorporados em uma mesma composição, e para produzir uma preparação farmacêutica sólida para administração oral
BRPI0910503A2 (pt) compostos, composições farmacêuticas e respectivos usos.
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0916877A2 (pt) composição farmacêutica e administração da mesma
BRPI1012892A2 (pt) composto, e, composição farmacêutica.
WO2012009723A8 (en) C-met modulator pharmaceutical compositions
EA201170772A1 (ru) Органические соединения
BRPI0819218A2 (pt) Métodos, estojos e composições para administração de compostos farmacêuticos
BRPI1009324A2 (pt) compostos e/ou farmaceuticamente aceitáveis dos mesmos, composição farmacêutica e respectivos usos
WO2008131114A3 (en) Pharmaceutical formulations containing lipoic acid derivatives
MA32383B1 (fr) DÉRIVÉS D'INDAZOLES à SUBSTITUTIONS PHÉNYLE ET BENZODIOXYNYLE
HK1164292A1 (en) Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same
DK3045164T3 (da) Vandige farmaceutiske sammensætninger, der indeholder borat-polyol-komplekser
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
DK2254549T3 (da) Vandige farmaceutiske sammensætninger, indeholdende borat-polyol-komplekser
UA111717C2 (uk) Склад для перорального введення і ліпофільні солі метилналтрексону
BR112012003280A2 (pt) composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto.
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
EA201101116A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
BR112015017251A2 (pt) composições farmacêuticas compreendendo doadores de nitroxil
BRPI0818483A2 (pt) Método para preparar uma composição farmacêutica, composição farmacêutica, e, uso da mesma.
BRPI0907228A2 (pt) Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos
EA201170512A1 (ru) Композиция для перорального введения
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
BR112012024428A2 (pt) composição farmacêutica de dissolução rápida

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.